We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Submission

Use of SuprathelR as a complete epidermal substitute in a boy with extensive toxic epidermal necrolysis

Submitted

28 Views
0 Downloads
2 Saves

Presentation

thumbnail

Abstract

Objectives Toxic epidermal necrolysis (TEN) is a rare, potentially life-threatening condition characterized by extensive loss of skin and mucosa of more than 30% total body surface area (TBSA). It is linked to certain drugs as well as viral or bacterial infections, resulting in a dysregulated immune reaction against epithelial cells. Treatment, as in thermal injuries, should include an early referral to a burn unit. This case report demonstrates a life-saving management of TEN with an epidermal substitute (Suprathel®) in a pediatric patient with epidermal damage of 100% TBSA. Methods A ten-year-old boy was admitted to our pediatric burn center complaining of foreign body sensation and photosensitivity of the eyes, headaches, pyrexia and presenting with extensive epidermolysis involving 100% TBSA. A skin biopsy confirmed the diagnosis of TEN with a complete loss of the epidermal layer as well as extensive mucosal involvement. The patient required fluid resuscitation and admission to the pediatric intensive care unit. Wound care consisted of gentle debridement of the blistered areas followed by extensive Suprathel® application. Results Repeated Suprathel® application maintained the skin barrier function over time and resulted in almost complete reepithelialization. The mucosa of the urogenital tract and eyes showed an almost complete restitution, as well. After a six-week inpatient stay the patient could be discharged to our outpatient care. Two years after treatment the patient is satisfied with the results and the skin is virtually free of scars with a normal appearance and elasticity. Conclusion In children, TEN with extensive epidermal loss is a rare, life-threatening condition that requires admission to a specialized pediatric burn unit. Suprathel® proves beneficial in the management of these cases by providing a skin barrier until natural reepithelialization occurs.

Datasets

No datasets are available for this submission.

License

No license information is available for this submission.

Morressier

Company

Legal

Follow us

© Copyright 2020 Morressier GmbH. All rights reserved.

Morressier

© Copyright 2020 Morressier GmbH.
All rights reserved.